Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer
Trial ID or NCT#
The goal of this study is to (i) improve detection of sentinel nodes and (ii) reduce additional surgical dissection that is needed in case a sentinel lymph node cannot be detected.
Concurrent Use of Lymphoseek and Indocyanine Green for Sentinel Lymph Node Detection in Endometrial Cancer - a Prospective Study
- - The patient has histological diagnosis of cancer of the endometrium of any histology or grade. - The patient should have received no prior treatment for her endometrial cancer. - The patient has clinically uterine confined disease. - The patient is a candidate for minimal invasive surgery, with sentinel lymph node assessment with IC-GREEN planned as part of standard of care. - The patient has an Eastern Cooperative Group (ECOG) performance status of 0-2. - If age less than or equal to 55 years, the patient has a negative pregnancy test within 72 hours before administration of Lymphoseek, has been surgically sterilized, or has been postmenopausal for at least 1 year. - The patient has provided written informed consent. - The patient is at least 18 years of age at the time of consent
- - The patient has clinical or radiological evidence of metastatic disease. - The patient has a history of a prior loop electrosurgical excision procedure (LEEP) or cone procedure performed on her cervix. - The patient has participated in another investigational drug study within 30 days of scheduled surgery. - The patient has an iodine allergy. - The patient is pregnant or lactating.
Contact us to find out if this trial is right for you.